grant

Identifying metabolic targets to reinvigorate T cell exhaustion

Organization JOHNS HOPKINS UNIVERSITYLocation BALTIMORE, UNITED STATESPosted 1 May 2025Deadline 30 Apr 2027
NIHUS FederalResearch GrantFY2025Adaptive Immune SystemAddressAntigensAssayBacteriaBioassayBiological AssayCAR T cell therapyCAR T therapyCD8 CellCD8 T cellsCD8 lymphocyteCD8+ T cellCD8+ T-LymphocyteCD8-Positive LymphocytesCD8-Positive T-LymphocytesCRISPRCRISPR activationCRISPR activatorCRISPR based activationCRISPR editing screenCRISPR gene activationCRISPR screenCRISPR transcription activationCRISPR transcriptional activationCRISPR-Cas-9-mediated gene activationCRISPR-based gene activationCRISPR-based screenCRISPR-dCAS9 ActivatorCRISPR-mediated transcriptional activationCRISPR/CAS9 activationCRISPR/CAS9 gene activationCRISPR/Cas systemCRISPR/Cas9 screenCRISPR/dCas9 activationCRISPR/dCas9-based transcriptional activationCRISPRaCancersCandidate Disease GeneCandidate GeneCatabolic ProcessCell Communication and SignalingCell FunctionCell Growth in NumberCell MultiplicationCell PhysiologyCell ProcessCell ProliferationCell SignalingCell SurvivalCell ViabilityCellular FunctionCellular Metabolic ProcessCellular PhysiologyCellular ProcessCellular ProliferationCellular biologyCheckpoint inhibitorChronicClustered Regularly Interspaced Short Palindromic RepeatsDataEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessExhibitsFailureFlow CytofluorometriesFlow CytofluorometryFlow CytometryFlow MicrofluorimetryFlow MicrofluorometryFutureGene ActivationGene ExpressionGene TranscriptionGeneralized GrowthGenerationsGenesGeneticGenetic TranscriptionGlycolysisGoalsGrowthGuide RNAHypoxiaHypoxicImmuneImmune checkpoint inhibitorImmune mediated therapyImmunesImmunityImmunologic SubtypingImmunologically Directed TherapyImmunophenotypingImmunotherapyImpairmentIn VitroInfectionInflammatoryIntermediary MetabolismIntracellular Communication and SignalingKnock-outKnockoutLC/MSLeadLibrariesLinkLong-term infectionMalignant NeoplasmsMalignant TumorMetabolicMetabolic PathwayMetabolic ProcessesMetabolismMiceMice MammalsModelingMolecularMurineMusNutrientOxidative PhosphorylationOxidative Phosphorylation PathwayOxygen DeficiencyPathway interactionsPb elementPhenotypePlayPopulationProcessProliferatingRNA ExpressionReceptor ProteinResistanceRestRoleSignal TransductionSignal Transduction SystemsSignalingSubcellular ProcessSystemT cell differentiationT cell responseT memory cellT-Cell DevelopmentT-Cell OntogenyT-CellsT-LymphocyteT-Lymphocyte DevelopmentT8 CellsT8 LymphocytesTeff cellTestingTherapeuticTherapeutic AgentsTissue GrowthTrans-Acting FactorsTrans-ActivatorsTransactivatorsTranscriptionTumor AntigensTumor-Associated AntigenVirusWorkacquired immune systemactivating CRISPR technologybiological signal transductioncancer antigenscancer microenvironmentcell biologycell metabolismcellular developmentcellular metabaolismchimeric antigen receptor (CAR) T cell therapychimeric antigen receptor T cell therapychimeric antigen receptor T therapychronic infectionclustered regularly interspaced short palindromic repeats screencytokineeffector T cellengineered T cellsepigeneticallyexhaustexhaustionexperienceexperimentexperimental researchexperimental studyexperimentsflow cytophotometryfunctional genomicsgRNAgain of functiongenetically engineered T-cellsheavy metal Pbheavy metal leadimmune check point inhibitorimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimmunogenimprovedin vivoinhibitorinhibitory surface receptorinsightinterestliquid chromatography mass spectrometryloss of functionmalignancymemory T lymphocytemetabolic fitnessmetabolic profilemetabolism measurementmetabolomicsmetabonomicsneoplasm/cancernovelnucleaseontogenyoverexpressoverexpressionpathogenpathwaypersistent infectionprogramsreceptorresistantresponsesocial rolethymus derived lymphocytetranscriptomicstransgenic T- cellstumortumor microenvironmenttumor-specific antigenuptake
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
CD8+ T cells are a critical component of the adaptive immune system and play an essential role in immune

defense against viruses, bacteria, and tumors. To achieve such a critical function in many different contexts,

CD8+ T cells have evolved to be highly adaptive by modulating cellular metabolism. Activated effector T cells

require high metabolic flux through anabolic growth-promoting pathways, while quiescent or more resting

states engage catabolic processes for ATP generation. After prolonged antigen exposure, CD8+ T cells can

become dysfunctional as they enter a distinct differentiation state known as T-cell exhaustion. This

dysfunctional state of T cells is characterized by stable expression of inhibitory surface receptors, poor

response to tumor antigens, and low cell proliferation and persistence of T cells in vivo, dampening immunity

and causing poor responsiveness to immune checkpoint inhibitors. Growing evidence indicates that exhausted

T cells are ‘metabolically insufficient’ with altered signaling cascades and transcriptional and epigenetic

landscapes. Metabolites are not simply byproducts of the differentiation of T cells, but metabolism itself may

dictate T cell exhaustion. Hence, modulating metabolism might reprogram or rewire certain states of T cell

differentiation. However, how metabolic rewiring drives and defines the differentiation of T cell exhaustion

remains unclear. We applied an untargeted liquid chromatography-mass spectrometry-based metabolomics

approach and found exhausted T cells display a distinct metabolic profile compared to functional effector T

cells. We thus hypothesize that chronic TCR stimulation imposes unique constraints on T cell

metabolism that can be targeted to reinvigorate exhausted T cells by overexpressing metabolic genes.

Encouraged by a striking metabolic difference between exhausted T cells and effector T cells, we will use

unbiased genetic and systems approaches to understand the functional relevance of metabolic pathways in

CD8+ T cell immunity. Several loss-of-function (LOF) screen studies have recently identified that remodeling

metabolism is intrinsically linked to cellular development, activation, function, differentiation, and survival in T-

cell biology. However, the comprehensive discovery of regulators requires both gain-of-function (GOF) and

LOF approaches. In Aim 1, we performed a functional genomic screen in vitro using a metabolism-focused

CRISPR activation library to identify potential gain-of-function metabolic targets that limit T cell persistence. In

Aim 2, we will determine the molecular mechanism by which the newly revealed GOF candidates reinvigorate

T cell exhaustion. The interactive analysis of the collected data will allow us to define the molecular

mechanisms by which metabolic pathways regulate T cell exhaustion. Collectively, we hope that our work will

provide insight into how to therapeutically modulate metabolism to restore exhausted T cells.

Grant Number: 1F31AI186227-01A1
NIH Institute/Center: NIH

Principal Investigator: Minsun Cha

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →